Speakers

Provided by Jim Mastrangelo

Leveraging the trailblazing work of Jamie Thomson at UW Madison, local biotech company JangoBio (and its companion animal division, JangoPet) are currently developing regenerative medicine approaches to the diseases of aging, including aging itself. Regenerative medicine seeks to repurpose a body’s innate mechanisms for healing and self-renewal to treat chronic disease and repair damaged, aging, or failing tissues. Current trials show considerable promise for the use of adult stem cells to treat osteoarthritis, evidencing increased mobility in treated dogs. (before and after video) JangoPet is working with the FDA’s Center for Veterinary Medicine to work toward regulatory approval of its highly purified and characterized stem cell mix to repair, renew, and regrow healthy tissue in a dog’s ailing joints.

At the same time, the company is testing therapies for “hypogonadism,” a reduced capability to maintain hormone balance (whether from age, injury, or medical intervention), a condition that afflicts over 2.4 billion people worldwide. This imbalance is directly correlated to age-related diseases like Alzheimer’s, heart disease, cancer, type II diabetes, and osteoporosis. Modulating hormone levels with stem cell technology could provide benefits to individuals (healthier, longer lives) as well as reduce the demand on our overburdened healthcare system.

Regenerative therapies, in both people and pets, are a matter of "when," not "if.”

Helping the elderly fight ID theft

Provided by Aaron Meyer

Provided by Rich Oliver

Provided by Steve Olson